Curis Reports Second Quarter 2018 Financial Results

Go back to Curis Reports Second Quarter 2018 Financial Results

Curis (CRIS) PT Lowered to $6 at Baird

August 3, 2018 7:12 AM EDT

Baird lowered its price target on Curis (NASDAQ: CRIS) to $6.00 (from $15.00) while maintaining an Outperform rating.

Analsyt Brian Skorney commented, "Curis announced 2Q18 earnings along with a pipeline update. The regulatory pathway for fimepinostat seems to be longer than... More

Curis (CRIS) Tops Q2 EPS by 13c

August 2, 2018 7:20 AM EDT

Curis (NASDAQ: CRIS) reported Q2 EPS of ($0.26), $0.13 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $2.34 million.

For earnings history and earnings-related data on Curis (CRIS) click here.

... More